Azor and Lantus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Lantus (insulin glargine recombinant). Common drug interactions include dehydration among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Lantus. It is created by eHealthMe based on reports of 90 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Lantus?

Lantus has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 191,782 Lantus users. Check the latest studies of Lantus.

On Aug, 09, 2026

90 people who take Azor and Lantus together, and have interactions are studied.

What are the common drug interactions of Azor and Lantus, by gender? *:

female:

Dehydration (dryness resulting from the removal of water)
Iritis (painful inflammation of the iris of the eye)
Ulcerative keratitis (ulcerative inflammation of the cornea)
Abdominal pain
Diarrhoea
Dizziness
Pain in extremity
Syncope (loss of consciousness with an inability to maintain postural tone)
Viral infection
Vomiting

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Chest pain
Drug hypersensitivity
Flushing (the warm, red condition of human skin)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Ataxia (loss of full control of bodily movements)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Diabetes mellitus inadequate control
Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)

What are the common drug interactions of Azor and Lantus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Flushing (the warm, red condition of human skin)

40-49:

Arthralgia (joint pain)
Localised infection (infection at the single location)
Neuropathic arthropathy (a progressive destruction of bone and joints)
Neuropathy peripheral (surface nerve damage)
Osteomyelitis (infection of bone)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pruritus (severe itching of the skin)
Rash
Urticaria (rash of round, red welts on the skin that itch intensely)
Abasia (inability to walk)

50-59:

Pain
Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon)
Viral infection
White blood cell count increased
Dyspnoea (difficult or laboured respiration)
Nephrogenic anaemia (anaemia due to kidney disease)
Blindness unilateral
Cataract (clouding of the lens inside the eye)
Corneal abrasion (loss of the surface of cornea)
Dry eye (lack of adequate tears)

60+:

Asthenia (weakness)
Chronic kidney disease
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood glucose decreased
Dyspnoea (difficult or laboured respiration)
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Anxiety
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Pain: 18 people, 20.00%
High Blood Cholesterol: 17 people, 18.89%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 16.67%
Stress And Anxiety: 11 people, 12.22%
Type 2 Diabetes: 7 people, 7.78%
Neuralgia (pain in one or more nerves): 7 people, 7.78%
Muscle Spasms (muscle contraction): 7 people, 7.78%
Multiple Myeloma (cancer of the plasma cells): 6 people, 6.67%
Depression: 6 people, 6.67%
Asthma: 6 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Lantus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously